Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board
HINGHAM, Mass., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which is continuing to expand its Key Opinion Leader (KOL) support network, today announced that Thierry Jacques De Baère, MD, PhD, is joining the Company’s Scientific Advisory Board (SAB). Dr. De Baère is head of the Interventional Radiology Unit at Institut Gustave Roussy Cancer Center in Villejuif, France, the largest cancer center in Europe. The Company’s SAB now includes 11 members from the U.S., Europe and Israel, who support the rising momentum for the Company’s LIBERTY® Robotic System.
- Dr. De Bare is head of the Interventional Radiology Unit at Institut Gustave Roussy Cancer Center in Villejuif, France, the largest cancer center in Europe.
- The Companys SAB now includes 11 members from the U.S., Europe and Israel, who support the rising momentum for the Companys LIBERTY Robotic System.
- Dr. De Bare is a leader in the endovascular space, who realized the potential of the LIBERTY Robotic System after his own personal experience.
- Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.